Alcohol and Cannabis Use Disorders Linked to Poorer Treatment Response in Adult ADHD, Small Study Finds
This study examines adult ADHD cannabis use disorder treatment response and finds that comorbid alcohol and cannabis use disorders reduce odds of clinical improvement. The small retrospective cohort highlights challenges in pharmacological treatment…
Psychosis After Quitting Cannabis: A Case Report Adds to Emerging Evidence
This case report highlights cannabis withdrawal psychosis in an older adult after abrupt cessation of heavy cannabis use. Psychotic symptoms resolved with short-term antipsychotic treatment. It underscores the need for clinical awareness of…
Cannabis Use Disorder Carries Greater Psychiatric Risk for Adolescents Than Adults, Study Finds
Cannabis use disorder adolescent psychiatry risks are significant and differ from those in adults. This study highlights elevated psychiatric risks in adolescents with cannabis use disorder. Understanding these risks is crucial for clinical care and…
Marijuana Use and Lower Obesity Rates: A Correlation, Not a Cure
The marijuana use obesity correlation shows obese individuals report 35% lower marijuana use than non-obese adults. This association is consistent but does not prove causation. Understanding this correlation helps clarify population-level trends without…
Alcohol and Cannabis Use Disorders Linked to Poorer ADHD Treatment Outcomes in Real-World Study
This study highlights the impact of adhd treatment cannabis use disorder on medication response in adults. Alcohol and cannabis use disorders reduce the likelihood of clinical improvement. Understanding these effects is crucial for managing ADHD with…
Cancer Patients With Medical Marijuana Cards Less Likely to Receive Excess Antiemetics, Arkansas Study Finds
A study of cancer patients found medical marijuana cardholder antiemetic overuse was significantly lower during chemotherapy. This suggests a potential role for cannabis in reducing excess antiemetic prescriptions. Further research is needed to confirm…
About 1 in 12 Cancer Survivors Used Cannabis, National Survey Finds
Roughly 1 in 12 cancer survivors reported cannabis use in 2021. Cannabis use cancer survivors data shows variation by demographic and state legalization status. Nearly half of users cited medical reasons for use.
Cannabis Prescriptions Did Not Lower Opioid Use in GI Cancer Patients Starting Chemotherapy
A large study of gastrointestinal cancer patients examined cannabinoid prescribing oncology opioid use GI cancer patterns after chemotherapy initiation. Only 2.4% received FDA-approved cannabinoid prescriptions, and those patients were more likely to use…
Marijuana Users Have Lower Obesity Rates, But Does the Drug Cause This?
Marijuana use obesity prevalence BRFSS data from 2016 to 2022 shows a consistent inverse association between marijuana use and obesity rates. This pattern is observed across demographic groups but does not prove causation. Understanding this relationship…
Cancer Survivors Report Little Cannabis Stigma but Opioid Stigma Influences Pain Choices
This study highlights cannabis opioid stigma cancer survivors experience, influencing their pain management choices. Most survivors report little direct cannabis stigma but significant opioid stigma. This dynamic affects symptom management and…